AGP Executive Report
Last update: 8 hours agoHealth & Medicines: The EU’s CHMP has issued a positive opinion for Eli Lilly’s Jaypirca (pirtobrutinib) to treat adults with chronic lymphocytic leukemia across all lines of therapy, now heading to the European Commission for final approval. Health & Medicines: EMA CHMP also recommended revoking EU marketing authorisation for Tavneos (avacopan) after questions over whether benefits still outweigh risks. Health & Medicines: Sanofi’s Cenrifki (tolebrutinib) has been approved by the European Commission for secondary progressive multiple sclerosis without relapses, positioning it as a disability-progression focused option. Arts, Culture & Community: Sarawak’s Rainforest Youth Summit (RAYS) 2026 opened in Kuching with new Timor-Leste participation, bringing youth voices into climate and sustainability dialogue. National Memory: In Dili, the Angolan ambassador paid tribute to former Timorese President Francisco Guterres “Lú-Olo,” with national mourning and a June 26 funeral set for Metinaro. Local Governance & Media: Timor-Leste’s Secretary of State for Local Development appeared on the “Government Page” TV show, highlighting decentralisation, community participation, and municipal development plans. Sports & Youth: A Timor-Leste observer presence was noted at Malaysia–Indonesia’s MALINDO exercise, reflecting growing regional interest.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.